Human Genome Epidemiology Literature Finder
Records 1 - 16 (of 16 Records) |
Query Trace: Neoplasms and UGT1A4[original query] |
---|
Genetic variations and haplotypes of UGT1A4 in a Japanese population. Drug metabolism and pharmacokinetics 2005 Apr 20 (2): 144-51. Saeki Mayumi, Saito Yoshiro, Jinno Hideto, Sai Kimie, Hachisuka Akiko, Kaniwa Nahoko, Ozawa Shogo, Kawamoto Manabu, Kamatani Naoyuki, Shirao Kuniaki, Minami Hironobu, Ohtsu Atsushi, Yoshida Teruhiko, Saijo Nagahiro, Komamura Kazuo, Kotake Takeshi, Morishita Hideki, Kamakura Shiro, Kitakaze Masafumi, Tomoike Hitonobu, Sawada Jun-ic |
Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 2008 Oct 29 (10): 1955-62. Figueroa Jonine D, Malats Núria, García-Closas Montserrat, Real Francisco X, Silverman Debra, Kogevinas Manolis, Chanock Stephen, Welch Robert, Dosemeci Mustafa, Lan Qing, Tardón Adonina, Serra Consol, Carrato Alfredo, García-Closas Reina, Castaño-Vinyals Gemma, Rothman Nathani |
Activity levels of tamoxifen metabolites at the estrogen receptor and the impact of genetic polymorphisms of phase I and II enzymes on their concentration levels in plasma. Clinical pharmacology and therapeutics 2011 May 89 (5): 708-17. Mürdter T E, Schroth W, Bacchus-Gerybadze L, Winter S, Heinkele G, Simon W, Fasching P A, Fehm T, , Eichelbaum M, Schwab M, Brauch |
Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenetics and genomics 2013 Jul 23 (7): 374-81. Innocenti Federico, Ramírez Jacqueline, Obel Jennifer, Xiong Julia, Mirkov Snezana, Chiu Yi-Lin, Katz David A, Carr Robert A, Zhang Wei, Das Soma, Adjei Araba, Moyer Ann M, Chen Pei Xian, Krivoshik Andrew, Medina Diane, Gordon Gary B, Ratain Mark J, Sahelijo Leonardo, Weinshilboum Richard M, Fleming Gini F, Bhathena Anahi |
Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics. Drug metabolism and disposition: the biological fate of chemicals 2013 Feb . Edavana VK, Dhakal IB, Williams S, Penney RB, Boysen G, Yao-Borengasser A, Kadlubar S |
UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokers. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Jan 24 (1): 94-104. Wassenaar Catherine A, Conti David V, Das Soma, Chen Peixian, Cook Edwin H, Ratain Mark J, Benowitz Neal L, Tyndale Rachel |
Impacts of the Glucuronidase Genotypes UGT1A4, UGT2B7, UGT2B15 and UGT2B17 on Tamoxifen Metabolism in Breast Cancer Patients. PloS one 2015 10 (7): e0132269. Romero-Lorca Alicia, Novillo Apolonia, Gaibar María, Bandrés Fernando, Fernández-Santander A |
Variations of chromosome 2 gene expressions among patients with lung cancer or non-cancer. Cell biology and toxicology 2016 Jun . Bao Lianmin, Zhang Yong, Wang Jian, Wang Haiyun, Dong Nian, Su Xiaoqiong, Xu Menglin, Wang Xiangdo |
Pharmacogenetics of UGT1A4, UGT2B7 and UGT2B15 and Their Influence on Tamoxifen Disposition in Asian Breast Cancer Patients. Clinical pharmacokinetics 2016 Apr . Sutiman Natalia, Lim Joanne Siok Liu, Muerdter Thomas E, Singh Onkar, Cheung Yin Bun, Ng Raymond Chee Hui, Yap Yoon Sim, Wong Nan Soon, Ang Peter Cher Siang, Dent Rebecca, Schroth Werner, Schwab Matthias, Khor Chiea Chuen, Chowbay Balr |
Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples. International journal of cancer research and molecular mechanisms 2015 Oct 1 (3): . Edavana Vineetha Koroth, Penney Rosalind B, Yao-Borengasser Aiwei, Starlard-Davenport Athena, Dhakal Ishwori B, Kadlubar Sus |
UDP-glucuronosyltransferase genetic variation in North African populations: a comparison with African and European data. Annals of human biology 2019 1 45 (6-8): 516-523. Novillo Apolonia, Gaibar María, Romero-Lorca Alicia, Chaabani Hassen, Amir Nadir, Moral Pedro, Esteban M Esther, Fernández-Santander A |
The Effect of Polymorphism in UGT1A4 on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Patients With Breast Cancer in China. Clinical breast cancer 2018 Dec . Lan Bo, Ma Fei, Han Mei, Chen Shanshan, Wang Wenna, Li Qiao, Fan Ying, Luo Yang, Cai Ruigang, Wang Jiayu, Yuan Peng, Zhang Pin, Li Qing, Xu Bing |
Representation of CYP3A4, CYP3A5 and UGT1A4 Polymorphisms within Croatian Breast Cancer Patients' Population. International journal of environmental research and public health 2020 May 17 (10): . Bojanic Kristina, Kuna Lucija, Bilic Curcic Ines, Wagner Jasenka, Smolic Robert, Kralik Kristina, Kizivat Tomislav, Ivanac Gordana, Vcev Aleksandar, Wu George Y, Smolic Marti |
Association between ESR1, ESR2, HER2, UGT1A4, and UGT2B7 polymorphisms and breast Cancer in Jordan: a case-control study. BMC cancer 2019 Dec 19 (1): 1257. Al-Eitan Laith N, Rababa'h Doaa M, Alghamdi Mansour A, Khasawneh Rame |
Effect of Food and Polymorphisms in SLCO2B1, CYP3A4 and UGT1A4 on Pharmacokinetics of Abiraterone and its Metabolites in Chinese Volunteers. British journal of clinical pharmacology 2023 8 . Yixin Hu, Jianyuan Wu, Bingyu Cheng, Rongli You, Xueyan Yin, Guiying Chen, Ling Yang, Yang Zhang, Luqin Si, Hongliang Jiang, Yongjun Zhang, Jianying Huang, Jiangeng Hua |
Breast cancer resistance protein polymorphism ABCG2 c.421C>A (rs2231142) moderates the effect of valproate on lamotrigine trough concentrations in adults with epilepsy. Fundamental & clinical pharmacology 2023 10 . Ivana Šušak Sporiš, Nada Božina, Iva Klarica Domjanovi?, Davor Sporiš, Silvio Baši?, Ivana Baši?, Mila Lovri?, Lana Ganoci, Vladimir Trkul |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: